Peter Dowd

It is a pleasure to see you in the Chair, Mr Efford. I find it difficult to believe that the hon. Member for Strangford (Jim Shannon) was a big fat pudding, but I suspect that even if he was, no one would have really noticed, given his charm and personality—I say that in all sincerity, as he knows. I thank my hon. Friend the Member for Worthing West (Dr Cooper) for being the driving force behind today’s debate. She has indicated that “people do better in more equal societies.” To some extent, as she made clear, that goes to the heart of what we are discussing. I will not repeat what she and other Members have said, but I will briefly discuss inequality in relation to my constituency. I also thank the British Liver Trust for its comprehensive and incredibly enlightening briefing on the issues that we face, which put into context the impact of those issues on our constituents. We are talking about individuals—mothers, fathers, sons, daughters and children—whose lives can be destroyed by this dreadful condition. My hon. Friend set the scene in relation to that. Time and again, the trust reinforced that fatty liver disease is a silent killer that is on the increase and clearly has been for a considerable time. To put that into context—some figures have been mentioned—there are about 19,000 deaths each year across the country. If my maths is right, that is about 52 deaths every day. In my constituency, that would equate to about 29 deaths a year, but I suspect the figure would be much higher if health inequalities were factored in, given that the rate of the disease is five times as high in the most deprived areas, of which mine is one. The figure in my constituency might be five times that amount —100 or 150 deaths a year. We should take into account that the average age of death is 61 for men and 62 for women, which, in this day and age, is really no age at all. In men, the chance of death is twice as high as in women. In that context, it is also important to emphasise that nine out of 10 cases of liver disease could be prevented. I hope that this debate will enable the calls to action by the British Liver Trust and by hon. Members to be heard in relation to prevention, early diagnosis, treatment and tackling inequalities. Perhaps the most sobering issue, which my hon. Friend the Member for Worthing West touched on, is the level of fatty liver disease in our children. She indicated that as many as 40% of children are affected in the more deprived areas, whereas in less deprived areas it is more like 14%—and even 14% is far too high. I am pleased that my hon. Friend has enabled us to look at this issue in more depth. I look forward to the responses from the Opposition spokespeople, the hon. Members for Sleaford and North Hykeham (Dr Johnson) and for Winchester (Dr Chambers), and of course my hon. Friend the Minister.